| Quality Indicator Set for Systemic Sclerosis |
 |
 |
 |
| Sunday, 10 July 2011 22:50 |
|
D. Khanna, O. Kowal-Bielecka, P.P. Khanna, A. Lapinska, S.M. Asch, N. Wenger, K.K. Brown, P. Clements, T. Getzug, M.D. Mayes, T.A. Medsger Jr., R. Oudiz, R. Simms, V. Steen, P. Maranian, D.E. Furst
Background: Systemic sclerosis (SSc) is associated with a marked economic burden, high treatment costs and decreased productivity. Although treatment strategies for SSc can have a substantial effect on patients’ outcomes, it is not known whether patients with SSc consistently receive such care. Evaluation of process-of-care quality requires specification of quality indicators (QIs), clinically detailed statements of the eligible patients and the care they should receive to achieve a minimal level of quality of care. Our objective was to develop QIs for patients with SSc. Methods: We performed a comprehensive literature review of diagnosis and treatment of SSc and proposed QIs that were evaluated by a national Expert Panel (n=9) who were asked to review the supporting literature and individually rank the validity of each QI. These rankings formed the basis of discussion at a face-to-face meeting following the RAND/UCLA method to integrate expert opinion with literature review to identify a set of final QIs. We then presented these QIs to members of the Scleroderma Clinical Trials Consortium (SCTC). Results: Thirty-two QIs for SSc care were judged valid by the Expert Panel. The QI set includes 9 QIs for newly diagnosed with SSc, 12 follow-up QIs for management of SSc, and 11 treatment QIs. The SCTC experts agreed with the validity of each of the 32 QI and agreed that for all but one QI the speci-fied tests, procedures and treatments recommended in the QI were generally available. Conclusion: We have developed 32 QIs for SSc using a rigorous methodology that can be employed to evaluate and improve care for patients with SSc, as well as inform policy decisions supporting appropriate care for SSc patients. Login to download your own copy of the full and original article from the link provided below |
More articles :
» 9 Essential Tips For A Health Kidney
Tip #1Drink 8-8 glasses of water in a gradual manner over the day. Gulping 8 glasses on a morning and thinking that you have flushed for the day is erroneous, as you would merely urinate more. So take a glassful at a time over the waking hours,...
» Platelet Gel In The Treatment Of Severe Scleroderma Skin Ulcers
Dilia Giuggioli, Michele Colaci, Andreina Manfredi, Mariateresa Mariano and Clodoveo FerriSystemic sclerosis (SSc) is characterized by microvascular damage and fibrosis of the skin and internal organs. Non-healing skin ulcers, mainly non-venous leg...
» Scleroderma Herbal Treatments
is a connective tissue disease. It causes the skin and internal organs to become hard and tight. This hardening can make it difficult for the sufferer to walk or move and can cause organs to fail. According to the Scleroderma Foundation, in the...
» Prevalence and Correlates of Sleep Disturbance in Systemic Sclerosis
Tracy Frech, Ron D. Hays, Paul Maranian, Philip J. Clements, Daniel E. Furst and Dinesh KhannaObjective:Rheumatologic disorders are associated with sleep disturbances. This study examines sleep disturbance correlates in patients with...
» Scleroderma Study Identifies Roadblocks To Employment
In the United States, the work disability rate for people with , also known as systemic sclerosis, is two to three times that of people with some other rheumatic conditions, according to research data from investigators at The (UTHealth) Medical...
» Basal Activation of Type I Interferons (Alpha2 and Beta) and 2'5'OAS Genes
Danilo Bretas de Oliveira, Gabriel Magno de Freitas Almeida, Antonio Carlos Martins Guedes, Flavia Patrıcia Sena Teixeira Santos, Claudio Antonio Bonjardim, Paulo Cesar Peregrino Ferreira, and Erna Geessien KroonReceived 15 June 2011; Revised 10...